SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WWS who wrote (49)10/10/1996 5:53:00 PM
From: Joseph Lapsansky   of 371
 
I'm just writing to keep this topic fresh. I realize there was just an outside chance of European approval of Leukoscan in September, but what about this month?
Also, if they are ready, I don't think they should wait for European approval befor they file and NDA in the U.S. It takes the FDA long enough to approve something.
It is obvious (now) that CEA-Scan just for colorectal is not getting the market excited enough. The ONLY reason I want to see this baby a little higher sooner rather than later is that it will increase my margin buying power. As far as the stock goes, I will hold this a long, long, time as the potential is REALLY there. And if they ever fall in love with this company even a third as much as Biogen, we will all be smiling. Joe Lapsansky
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News